Related references
Note: Only part of the references are listed.Misfolded PrP impairs the UPS by interaction with the 20S proteasome and inhibition of substrate entry
Pelagia Deriziotis et al.
EMBO JOURNAL (2011)
Expression of Mutant or Cytosolic PrP in Transgenic Mice and Cells Is Not Associated with Endoplasmic Reticulum Stress or Proteasome Dysfunction
Elena Quaglio et al.
PLOS ONE (2011)
Rapid cell-surface prion protein conversion revealed using a novel cell system
R. Goold et al.
NATURE COMMUNICATIONS (2011)
Interactions of PAN's C-termini with archaeal 20S proteasome and implications for the eukaryotic proteasome-ATPase interactions
Yadong Yu et al.
EMBO JOURNAL (2010)
Enhancement of proteasome activity by a small-molecule inhibitor of USP14
Byung-Hoon Lee et al.
NATURE (2010)
Cell-produced α-synuclein oligomers are targeted to, and impair, the 26S proteasome
Evangelia Emmanouilidou et al.
NEUROBIOLOGY OF AGING (2010)
Depletion of 26S proteasomes in mouse brain neurons causes neurodegeneration and Lewy-like inclusions resembling human pale bodies
Lynn Bedford et al.
JOURNAL OF NEUROSCIENCE (2008)
Aβ inhibits the proteasome and enhances amyloid and tau accumulation
Bertrand P. Tseng et al.
NEUROBIOLOGY OF AGING (2008)
Docking of the proteasomal ATPases' carboxyl termini in the 20S proteasome's α ring opens the gate for substrate entry
David M. Smith et al.
MOLECULAR CELL (2007)
Global changes to the ubiquitin system in Huntington's disease
Eric J. Bennett et al.
NATURE (2007)
Disease-associated prion protein oligomers inhibit the 26S proteasome
Mark Kristiansen et al.
MOLECULAR CELL (2007)
Oligomerization of the human prion protein proceeds via a molten globule intermediate
Remo Gerber et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2007)
The roles of intracellular protein-degradation pathways in neurodegeneration
David C. Rubinsztein
NATURE (2006)
Formation of soluble oligomers and amyloid fibrils with physical properties of the scrapie isoform of the prion protein from the C-terminal domain of recombinant murine prion protein mPrP-(121-231)
Samantha M. Martins et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2006)
Proteasome impairment does not contribute to pathogenesis in R6/2 Huntington's disease mice: exclusion of proteasome activator REG gamma as a therapeutic target
JS Bett et al.
HUMAN MOLECULAR GENETICS (2006)
The 1.9 A structure of a proteasome-11S activator complex and implications for proteasome-PAN/PA700 interactions
A Förster et al.
MOLECULAR CELL (2005)
Neuronal dysfunction in a polyglutamine disease model occurs in the absence of ubiquitin-proteasome system impairment and inversely correlates with the degree of nuclear inclusion formation
AB Bowman et al.
HUMAN MOLECULAR GENETICS (2005)
Prion protein is ubiquitinated after developing protease resistance in the brains of scrapie-infected mice
SC Kang et al.
JOURNAL OF PATHOLOGY (2004)
Proteasomal inhibition by α-synuclein filaments and oligomers
E Lindersson et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2004)
The ubiquitin-proteasome proteolytic pathway: Destruction for the sake of construction
MH Glickman et al.
PHYSIOLOGICAL REVIEWS (2002)
Post-natal knockout of prion protein alters hippocampal CA1 properties, but does not result in neurodegeneration
GR Mallucci et al.
EMBO JOURNAL (2002)
Impairment of the ubiquitin-proteasome system by protein aggregation
NF Bence et al.
SCIENCE (2001)
Structural basis for the activation of 20S proteasomes by 11S regulators
FG Whitby et al.
NATURE (2000)
A gated channel into the proteasome core particle
M Groll et al.
NATURE STRUCTURAL BIOLOGY (2000)
Impaired proteasome function in Alzheimer's disease
JN Keller et al.
JOURNAL OF NEUROCHEMISTRY (2000)
Share Paper
